Recent TBI Stock Price | TBI Stock Predictions | |
$10.53 | +94.68% |
$20.50 |
Recent TBI Analyst Ratings Breakdown, Making TBI Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 3 | 3 | 3 | 3 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 1 | 1 | 1 | 1 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.5 | 1.5 | 1.5 | 1.5 |
For the TBI stock predictions from the analysts covering TrueBlue Inc, we have collected all of the individual TBI stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 4 different analysts covering TBI (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since TBI stock predictions may vary widely, another useful metric to consider is the median TBI stock prediction, which represents the price at which half of the analysts
made TBI stock predictions that were higher and half made TBI stock predictions that were lower. This makes for a different take on the TBI stock predictions out there, as compared to average or mean.
And that median across all the individual TBI stock predictions was: $15.0 as of 2024-05-03.
The very highest of the TBI stock predictions for one year price target was $38.0, while the very lowest of the TBI stock predictions in the analyst group was
$14.0 (with a standard deviation of $11.676). Get the latest Zacks research report on TBI — FREE
Find out: TBI next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
GLYC Stock Predictions
PDFS Stock Predictions
PRAA Stock Predictions
CIVB Stock Predictions
CLR Stock Predictions
ZTO Stock Predictions
RAD Stock Predictions
DPZ Stock Predictions
MBIO Stock Predictions
|
|
Strong Buy (3.50 out of 4) 59th percentile
(ranked higher than approx. 59% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |